C112Y (p.Cys112Tyr) variant of UMOD (Uromodulin)

C112Y (p.Cys112Tyr) in UMOD (Uromodulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Familial juvenile hyperuricemic nephropathy type 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.89 / 1. The record also includes published literature and structural context.

C112Y (p.Cys112Tyr) variant details